Clinical features of SARS-CoV-2 Omicron BA.2; Lessons from previous observations - Correspondence

被引：2
|
作者：
Sahebi, Saeed [1 ]
Keikha, Masoud [2 ]
机构：
[1] Mashhad Univ Med Sci, Student Res Comm, Fac Med, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Fac Med, Dept Microbiol & Virol, Mashhad, Razavi Khorasan, Iran
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2022年 / 104卷
关键词：
D O I：
10.1016/j.ijsu.2022.106754
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
    Arora, Prerna
    Zhang, Lu
    Rocha, Cheila
    Sidarovich, Anzhalika
    Kempf, Amy
    Schulz, Sebastian
    Cossmann, Anne
    Manger, Bernhard
    Baier, Eva
    Tampe, Bjoern
    Moerer, Onnen
    Dickel, Steffen
    Dopfer-Jablonka, Alexandra
    Jaeck, Hans-Martin
    Behrens, Georg M. N.
    Winkler, Martin S.
    Poehlmann, Stefan
    Hoffmann, Markus
    LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 766 - 767
  • [42] Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
    Li, Gen
    Zhou, Zhongcheng
    Du, Peng
    Zhan, Meixiao
    Li, Ning
    Xiong, Xinxin
    Tang, Shengjun
    Man, Miao
    Baptista-Hon, Daniel T.
    Lu, Ligong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [43] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tamura, Tomokazu
    Yamasoba, Daichi
    Oda, Yoshitaka
    Ito, Jumpei
    Kamasaki, Tomoko
    Nao, Naganori
    Hashimoto, Rina
    Fujioka, Yoichiro
    Suzuki, Rigel
    Wang, Lei
    Ito, Hayato
    Kashima, Yukie
    Kimura, Izumi
    Kishimoto, Mai
    Tsuda, Masumi
    Sawa, Hirofumi
    Yoshimatsu, Kumiko
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Kanamune, Jun
    Suzuki, Yutaka
    Ohba, Yusuke
    Tabata, Kaori
    Yokota, Isao
    Matsuno, Keita
    Takayama, Kazuo
    Tanaka, Shinya
    Sato, Kei
    Fukuhara, Takasuke
    COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [44] Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
    Jing Zou
    Chaitanya Kurhade
    Hongjie Xia
    Mingru Liu
    Xuping Xie
    Ping Ren
    Pei-Yong Shi
    Nature Communications, 13
  • [45] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tomokazu Tamura
    Daichi Yamasoba
    Yoshitaka Oda
    Jumpei Ito
    Tomoko Kamasaki
    Naganori Nao
    Rina Hashimoto
    Yoichiro Fujioka
    Rigel Suzuki
    Lei Wang
    Hayato Ito
    Yukie Kashima
    Izumi Kimura
    Mai Kishimoto
    Masumi Tsuda
    Hirofumi Sawa
    Kumiko Yoshimatsu
    Yuki Yamamoto
    Tetsuharu Nagamoto
    Jun Kanamune
    Yutaka Suzuki
    Yusuke Ohba
    Isao Yokota
    Keita Matsuno
    Kazuo Takayama
    Shinya Tanaka
    Kei Sato
    Takasuke Fukuhara
    Communications Biology, 6
  • [46] Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant
    Gen Li
    Zhongcheng Zhou
    Peng Du
    Meixiao Zhan
    Ning Li
    Xinxin Xiong
    Shengjun Tang
    Miao Man
    Daniel T. Baptista-Hon
    Ligong Lu
    Signal Transduction and Targeted Therapy, 7
  • [47] Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
    Kimura, Izumi
    Yamasoba, Daichi
    Tamura, Tomokazu
    Nao, Naganori
    Suzuki, Tateki
    Oda, Yoshitaka
    Mitoma, Shuya
    Ito, Jumpei
    Nasser, Hesham
    Zahradnik, Jiri
    Uriu, Keiya
    Fujita, Shigeru
    Kosugi, Yusuke
    Wang, Lei
    Tsuda, Masumi
    Kishimoto, Mai
    Ito, Hayato
    Suzuki, Rigel
    Shimizu, Ryo
    Begum, Mst Monira
    Yoshimatsu, Kumiko
    Kimura, Kanako Terakado
    Sasaki, Jiei
    Sasaki-Tabata, Kaori
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Kanamune, Jun
    Kobiyama, Kouji
    Asakura, Hiroyuki
    Nagashima, Mami
    Sadamasu, Kenji
    Yoshimura, Kazuhisa
    Shirakawa, Kotaro
    Takaori-Kondo, Akifumi
    Kuramochi, Jin
    Schreiber, Gideon
    Ishii, Ken J.
    Hashiguchi, Takao
    Ikeda, Terumasa
    Saito, Akatsuki
    Fukuhara, Takasuke
    Tanaka, Shinya
    Matsuno, Keita
    Sato, Kei
    CELL, 2022, 185 (21) : 3992 - +
  • [48] Vaccination status for mild and asymptomatic infections with SARS-CoV-2 Omicron BA.2 variant in Shanghai
    Yin, Yong
    Lin, Jilei
    Yuan, Shuhua
    Tong, Shilu
    He, Yi
    Dong, Bin
    Zhang, Fen
    Chen, Erzhen
    Zheng, Junhua
    Wang, Wei
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (05)
  • [49] Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
    Evans, John P.
    Zeng, Cong
    Qu, Panke
    Faraone, Julia
    Zheng, Yi-Min
    Carlin, Claire
    Bednash, Joseph S.
    Zhou, Tongqing
    Lozanski, Gerard
    Mallampalli, Rama
    Saif, Linda J.
    Oltz, Eugene M.
    Mohler, Peter J.
    Xu, Kai
    Gumina, Richard J.
    Liu, Shan-Lu
    CELL HOST & MICROBE, 2022, 30 (08) : 1093 - +
  • [50] Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
    Zou, Jing
    Kurhade, Chaitanya
    Xia, Hongjie
    Liu, Mingru
    Xie, Xuping
    Ren, Ping
    Shi, Pei-Yong
    NATURE COMMUNICATIONS, 2022, 13 (01)
12345